[Behavior of anti-HBc IgM in acute and chronic hepatitis]. 1985

A Ajello, and M A Freni, and A Smedile, and M L Resta, and G Berlinghieri, and A Spadaro, and I Calapristi, and O Ferraù

Anti-HBV core IgM antibodies (anti-HBc IgM) were tested by RIA in the sera from 269 patients with acute viral hepatitis (AVH), from 39 patients with chronic HBSAg+ hepatitis (CH) at various stage of evolution, in 41 asymptomatic HBsAg carriers and in 30 healthy volunteers. Anti-HBc IgM were found in 100/108 HBsAg+ AVH, in 6/161 HBsAg--AVH, in 9/39 with CH and only 1 asymptomatic HBsAg carrier. Among the chronic patients with anti-HBc IgM, 3 were HBeAg+ and 6 were anti-HBe+. The test of anti-HBc IgM results useful in the early aetiological diagnosis of acute hepatitis since it is always positive in HBV acute hepatitis even in the subjects who early seroconvert to anti-HBs; the absence of anti-HBc IgM in the HBsAg+ acute hepatitis suggests other overinfecting agents. The presence of anti-HBc IgM in CH seems not to be related to an active viral replication.

UI MeSH Term Description Entries
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D006510 Hepatitis B Antibodies Antibodies to the HEPATITIS B ANTIGENS, including antibodies to the surface (Australia) and core of the Dane particle and those to the "e" antigens. Anti-Australia Antigens,Anti-HBAg,Anti-Hepatitis B Antigens,Anti HBAg,Hepatitis B Virus Antibodies,Anti Australia Antigens,Anti Hepatitis B Antigens,Antibodies, Hepatitis B,Antigens, Anti-Australia,Antigens, Anti-Hepatitis B,B Antibodies, Hepatitis,B Antigens, Anti-Hepatitis,HBAg, Anti
D006525 Hepatitis, Viral, Human INFLAMMATION of the LIVER in humans due to infection by VIRUSES. There are several significant types of human viral hepatitis with infection caused by enteric-transmission (HEPATITIS A; HEPATITIS E) or blood transfusion (HEPATITIS B; HEPATITIS C; and HEPATITIS D). Viral Hepatitis, Human,Human Viral Hepatitides,Human Viral Hepatitis,Viral Hepatitides, Human
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A Ajello, and M A Freni, and A Smedile, and M L Resta, and G Berlinghieri, and A Spadaro, and I Calapristi, and O Ferraù
January 1981, Die Medizinische Welt,
A Ajello, and M A Freni, and A Smedile, and M L Resta, and G Berlinghieri, and A Spadaro, and I Calapristi, and O Ferraù
September 1984, Klinische Wochenschrift,
A Ajello, and M A Freni, and A Smedile, and M L Resta, and G Berlinghieri, and A Spadaro, and I Calapristi, and O Ferraù
November 2006, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology,
A Ajello, and M A Freni, and A Smedile, and M L Resta, and G Berlinghieri, and A Spadaro, and I Calapristi, and O Ferraù
June 1985, Medicina clinica,
A Ajello, and M A Freni, and A Smedile, and M L Resta, and G Berlinghieri, and A Spadaro, and I Calapristi, and O Ferraù
April 2015, World journal of gastroenterology,
A Ajello, and M A Freni, and A Smedile, and M L Resta, and G Berlinghieri, and A Spadaro, and I Calapristi, and O Ferraù
December 1981, Liver,
A Ajello, and M A Freni, and A Smedile, and M L Resta, and G Berlinghieri, and A Spadaro, and I Calapristi, and O Ferraù
October 1984, Radioisotopes,
A Ajello, and M A Freni, and A Smedile, and M L Resta, and G Berlinghieri, and A Spadaro, and I Calapristi, and O Ferraù
January 1987, Hepatology (Baltimore, Md.),
A Ajello, and M A Freni, and A Smedile, and M L Resta, and G Berlinghieri, and A Spadaro, and I Calapristi, and O Ferraù
July 1982, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology,
A Ajello, and M A Freni, and A Smedile, and M L Resta, and G Berlinghieri, and A Spadaro, and I Calapristi, and O Ferraù
September 1990, Journal of clinical pathology,
Copied contents to your clipboard!